Chairman and CEO
Barry R. Edwards served as CEO of Impax Laboratories (NASDAQ: IPXL) from 2004 to 2006, and as Co-CEO from 1999 through 2004. Earlier, he spent twelve years with Teva Pharmaceuticals, where he was Vice President, Marketing and Business Development, and Executive Director of Gate Pharmaceuticals, a brand marketing division of Teva Pharmaceuticals USA. Mr. Edwards begin his career by working for Harris Hollin at the Lemmon Company, which had been a small regional company that Hollin transformed into a dynamic mainstream pharmaceutical company with national and international reach.
Ms. Pendergast was deputy commissioner and senior advisor to the Commissioner, Food and Drug Administration, Department of Health and Human Services from 1990 to 1998. After 16 years in senior posts with the FDA, Ms. Pendergast served as executive vice president, government affairs for Elan Corporation from 1998 to 2003. Since September 2003, Ms. Pendergast has been president of Pendergast Consulting. Ms. Pendergast received her LL.M. from Yale Law School in 1977, her J.D. from the University of Iowa College of Law in 1976 and her B.A. from Northwestern University in 1972.